Modern mammography screening and breast cancer mortality: population study
- PMID: 24951459
- PMCID: PMC4061379
- DOI: 10.1136/bmj.g3701
Modern mammography screening and breast cancer mortality: population study
Abstract
Objective: To evaluate the effectiveness of contemporary mammography screening using individual information about screening history and breast cancer mortality from public screening programmes.
Design: Prospective cohort study of Norwegian women who were followed between 1986 and 2009. Within that period (1995-2005), a national mammography screening programme was gradually implemented, with biennial invitations sent to women aged 50-69 years.
Participants: All Norwegian women aged 50-79 between 1986 and 2009.
Main outcome measures: Multiple Poisson regression analysis was used to estimate breast cancer mortality rate ratios comparing women who were invited to screening (intention to screen) with women who were not invited, with a clear distinction between cases of breast cancer diagnosed before (without potential for screening effect) and after (with potential for screening effect) the first invitation for screening. We took competing causes of death into account by censoring women from further follow-up who died from other causes. Based on the observed mortality reduction combined with the all cause and breast cancer specific mortality in Norway in 2009, we used the CISNET (Cancer Intervention and Surveillance Modeling Network) Stanford simulation model to estimate how many women would need to be invited to biennial mammography screening in the age group 50-69 years to prevent one breast cancer death during their lifetime.
Results: During 15 193 034 person years of observation (1986-2009), deaths from breast cancer occurred in 1175 women with a diagnosis after being invited to screening and 8996 women who had not been invited before diagnosis. After adjustment for age, birth cohort, county of residence, and national trends in deaths from breast cancer, the mortality rate ratio associated with being invited to mammography screening was 0.72 (95% confidence interval 0.64 to 0.79). To prevent one death from breast cancer, 368 (95% confidence interval 266 to 508) women would need to be invited to screening.
Conclusion: Invitation to modern mammography screening may reduce deaths from breast cancer by about 28%.
© Weedon-Fekjær et al 2014.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Comment in
-
The harms and benefits of modern screening mammography.BMJ. 2014 Jun 17;348:g3824. doi: 10.1136/bmj.g3824. BMJ. 2014. PMID: 24938686 No abstract available.
Similar articles
-
Mammography screening in the county of Fyn. November 1993-December 1999.APMIS Suppl. 2003;(110):1-33. APMIS Suppl. 2003. PMID: 12739252
-
Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.APMIS Suppl. 1998;83:1-44. APMIS Suppl. 1998. PMID: 9850674
-
Digital Breast Tomosynthesis with Hologic 3D Mammography Selenia Dimensions System for Use in Breast Cancer Screening: A Single Technology Assessment [Internet].Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2017 Sep 4. Report from the Norwegian Institute of Public Health No. 2017-08. PMID: 29553669 Free Books & Documents. Review.
-
Mammography screening: A major issue in medicine.Eur J Cancer. 2018 Feb;90:34-62. doi: 10.1016/j.ejca.2017.11.002. Epub 2017 Dec 20. Eur J Cancer. 2018. PMID: 29272783
-
Benefits and Harms of Breast Cancer Screening: A Systematic Review.JAMA. 2015 Oct 20;314(15):1615-34. doi: 10.1001/jama.2015.13183. JAMA. 2015. PMID: 26501537 Review.
Cited by
-
DF-dRVFL: A novel deep feature based classifier for breast mass classification.Multimed Tools Appl. 2024;83(5):14393-14422. doi: 10.1007/s11042-023-15864-2. Epub 2023 Jul 11. Multimed Tools Appl. 2024. PMID: 38283725 Free PMC article.
-
Oestrogen receptor low positive breast cancer: associations with prognosis.Breast Cancer Res Treat. 2023 Oct;201(3):535-545. doi: 10.1007/s10549-023-07040-9. Epub 2023 Jul 18. Breast Cancer Res Treat. 2023. PMID: 37462784 Free PMC article.
-
Vision-Transformer-Based Transfer Learning for Mammogram Classification.Diagnostics (Basel). 2023 Jan 4;13(2):178. doi: 10.3390/diagnostics13020178. Diagnostics (Basel). 2023. PMID: 36672988 Free PMC article.
-
Interpreting Breast Cancer Mortality Trends Related to Introduction of Mammography Screening: A Simulation Study.MDM Policy Pract. 2022 Oct 8;7(2):23814683221131321. doi: 10.1177/23814683221131321. eCollection 2022 Jul-Dec. MDM Policy Pract. 2022. PMID: 36225967 Free PMC article.
-
Patchless Multi-Stage Transfer Learning for Improved Mammographic Breast Mass Classification.Cancers (Basel). 2022 Mar 1;14(5):1280. doi: 10.3390/cancers14051280. Cancers (Basel). 2022. PMID: 35267587 Free PMC article.
References
-
- Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19. - PubMed
-
- World Health Organization. IARC handbooks of cancer prevention: handbook 7: breast cancer screening. IARC Press; 2001.
-
- Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34. - PubMed
-
- Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women. Early Breast Cancer Trialists’ Collaborative Group. N Engl J Med 1988;319:1681-92. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical